Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biom J. 2017 May 16;59(6):1277–1300. doi: 10.1002/bimj.201600235

Figure 10.

Figure 10

Predicted probability of death within 5 years, P(T ≤ τ + 5|T > τ,Z(τ),X) for two individuals in the prostate cancer dataset. Individual A (left) is 60 years old at baseline, with PSA 19.7 ng/mL, Gleason score 7.5 (“4+3”), T1 Stage, 6 comorbidities, and does not experience clinical failure but dies 10 years from baseline. Individual B (right) is 54 years old at baseline, with PSA 16 ng/mL, Gleason score 9, T2 Stage, zero comorbidities, and experiences clinical failure at time 3 before dying at time 4.6 years from baseline. Black dashed line indicates time of death.